Société Bristol-Myers Squibb Company Buenos Aires S.E.
Actions
BMY
ARDEUT112877
Produits pharmaceutiques
Cours en clôture
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
16 212 ARS | +0,39 % | +0,32 % | -1,48 % |
16/05 | Bristol Myers Squibb : Chubb, Cisco, Walmart... les valeurs à suivre à Wall Street - | AO |
16/05 | Bristol Myers Squibb: approbation accélérée pour le traitement anti-lymphome | AO |
Métier
70,1% du CA est réalisé aux Etats-Unis.
Nombre d'employés: 34 100
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Innovative Medicines
100,0
%
| 46 159 | 100,0 % | 45 006 | 100,0 % | -2,50 % |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
70,1
%
| 31 828 | 69,0 % | 31 555 | 70,1 % | -0,86 % |
International
28,3
%
| 13 497 | 29,2 % | 12 752 | 28,3 % | -5,52 % |
Other
1,6
%
| 834 | 1,8 % | 699 | 1,6 % | -16,19 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 53 | 01/02/15 | |
David Elkins
DFI | Director of Finance/CFO | 55 | 20/11/19 |
Greg Meyers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Compliance Officer | - | 01/01/03 | |
Chief Tech/Sci/R&D Officer | - | - | |
Samit Hirawat
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/01/19 |
Robert Plenge
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/11/19 |
Laura Hortas
IRO | Public Communications Contact | - | - |
Corporate Officer/Principal | - | - | |
Cari Gallman
PRN | Corporate Officer/Principal | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Phyllis Yale
BRD | Director/Board Member | 66 | 20/11/19 |
Peter Arduini
BRD | Director/Board Member | 59 | 01/04/16 |
Derica Rice
BRD | Director/Board Member | 59 | 01/09/20 |
Paula Price
BRD | Director/Board Member | 62 | 01/09/20 |
Theodore Samuels
BRD | Director/Board Member | 69 | 21/02/17 |
David Elkins
DFI | Director of Finance/CFO | 55 | 20/11/19 |
Chief Executive Officer | 53 | 01/02/15 | |
Julia Haller
BRD | Director/Board Member | 69 | 20/11/19 |
Deepak Bhatt
BRD | Director/Board Member | 56 | 14/06/22 |
Karen Vousden
BRD | Director/Board Member | 66 | 01/01/18 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 2 923 100 096 | 2 024 918 592 ( 69,27 %) | 896 000 000 ( 30,65 %) | 69,27 % |
Participations
Nom | Actions | % | Valorisation |
---|---|---|---|
5 075 304 | 6,37% | 120 944 494 $ | |
KURA ONCOLOGY, INC. 1,80% | 1 370 171 | 1,80% | 26 033 249 $ |
KURA ONCOLOGY, INC. 6,36% | 759 145 | 6,36% | 21 438 255 $ |
COMPUGEN LTD. 5,31% | 4 757 058 | 5,31% | 9 546 749 $ |
CELULARITY INC. 5,49% | 1 195 327 | 5,49% | 3 669 654 $ |
Coordonnées société
Bristol Myers Squibb Co.
Route 206 & Province Line Road
08543, Princeton
+609 252 4621
http://www.bms.comSociétés du groupe
Nom | Catégorie et Secteur |
---|---|
Bristol-Myers Squibb India Pvt Ltd.
Bristol-Myers Squibb India Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb India Pvt Ltd. discovers, develops and delivers medicines for immuno-oncology. The company is based in Mumbai, India. |
Pharmaceuticals: Major
|
Bristol-Myers Squibb de México S de RL de CV
Bristol-Myers Squibb de México S de RL de CV Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb de México S de RL de CV is a Mexican company that manufactures and supplies pharmaceutical and nutritional products. The company is located in Mexico. |
Pharmaceuticals: Major
|
Celgene Kappa Holdings LLC
| |
Bristol-Myers Squibb International Co. ULC
| |
Bristol-Myers Squibb Holdings Germany Verwaltungs GmbH
| |
Seamair Insurance DAC
| |
Bristol-Myers Squibb AE
| |
Swords Laboratories Unlimited Co.
Swords Laboratories Unlimited Co. Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Swords Laboratories Unlimited Co. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Swords, Ireland. |
Pharmaceuticals: Major
|
BMS Strategic Portfolio Investments Holdings, Inc.
|
Secteur
Ventes par région
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+32,09 % | 693 Md | |
+29,39 % | 584 Md | |
-1,34 % | 372 Md | |
+20,34 % | 332 Md | |
+7,39 % | 294 Md | |
+14,25 % | 239 Md | |
-3,03 % | 211 Md | |
+10,02 % | 210 Md | |
+8,49 % | 168 Md |
- Bourse
- Actions
- Action BMY
- Action BMY
- Société Bristol-Myers Squibb Company